David Parr

4.1k total citations
50 papers, 1.8k citations indexed

About

David Parr is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, David Parr has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 9 papers in Cancer Research. Recurrent topics in David Parr's work include Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). David Parr is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). David Parr collaborates with scholars based in United Kingdom, Netherlands and Sweden. David Parr's co-authors include Robert A. Stockley, Jan Stolk, Berend C. Stoel, Asger Dirksen, Eeva Piitulainen, Marion Wencker, C. Q. Deng, S. B. Shaker, P Guest and Lee Dowson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

David Parr

46 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Parr United Kingdom 18 1.3k 580 441 326 189 50 1.8k
Nagi F. Khouri United States 22 1.4k 1.1× 315 0.5× 313 0.7× 165 0.5× 15 0.1× 49 2.3k
Rocco Trisolini Italy 30 2.3k 1.8× 181 0.3× 636 1.4× 518 1.6× 27 0.1× 129 3.0k
Yoshiki Demura Japan 24 856 0.7× 123 0.2× 314 0.7× 153 0.5× 17 0.1× 83 1.5k
Masako Chiyo Japan 27 2.1k 1.7× 118 0.2× 435 1.0× 165 0.5× 23 0.1× 57 2.9k
Hubert de Crémoux France 19 806 0.6× 88 0.2× 410 0.9× 176 0.5× 27 0.1× 48 1.2k
Hirokazu Taniguchi Japan 18 426 0.3× 136 0.2× 346 0.8× 112 0.3× 28 0.1× 103 1.3k
Jean M. Seely Canada 24 1.1k 0.9× 213 0.4× 425 1.0× 105 0.3× 11 0.1× 102 2.0k
J.-W.J. Lammers Netherlands 25 864 0.7× 37 0.1× 109 0.2× 359 1.1× 103 0.5× 45 1.6k
Ian Woolhouse United Kingdom 16 1.3k 1.0× 89 0.2× 223 0.5× 122 0.4× 14 0.1× 37 1.5k
Carlos A. Jiménez United States 26 1.4k 1.1× 67 0.1× 262 0.6× 143 0.4× 79 0.4× 82 1.8k

Countries citing papers authored by David Parr

Since Specialization
Citations

This map shows the geographic impact of David Parr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Parr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Parr more than expected).

Fields of papers citing papers by David Parr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Parr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Parr. The network helps show where David Parr may publish in the future.

Co-authorship network of co-authors of David Parr

This figure shows the co-authorship network connecting the top 25 collaborators of David Parr. A scholar is included among the top collaborators of David Parr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Parr. David Parr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stockley, Robert A. & David Parr. (2024). Antitrypsin deficiency: still more to learn about the lung after 60 years. ERJ Open Research. 10(4). 139–2024. 1 indexed citations
2.
Parr, David, Joanna Chorostowska‐Wynimko, Angelo Guido Corsico, et al.. (2022). Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration. Archivos de Bronconeumología. 58(12). 840–842. 7 indexed citations
3.
Kahal, Hassan, Ioannis Kyrou, Olalekan A. Uthman, et al.. (2019). The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep And Breathing. 24(1). 339–350. 52 indexed citations
4.
5.
Miravitlles, Marc, Asger Dirksen, Ilaria Ferrarotti, et al.. (2017). European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. European Respiratory Journal. 50(5). 1700610–1700610. 203 indexed citations
6.
Parr, David, et al.. (2016). Lung density associates with survival in alpha 1 antitrypsin deficient patients. Respiratory Medicine. 112. 81–87. 27 indexed citations
7.
Woodhead, Felix, et al.. (2014). Comparison of physiological impairment in ILD patients with and without diagnostic IPF features. European Respiratory Journal. 44(Suppl 58). P3757–P3757. 1 indexed citations
8.
Subramanian, Deepak, et al.. (2012). Assessment of Pulmonary Neutrophilic Inflammation in Emphysema by Quantitative Positron Emission Tomography. American Journal of Respiratory and Critical Care Medicine. 186(11). 1125–1132. 49 indexed citations
9.
Subramanian, Deepak, Sumit Gupta, Loems Ziegler‐Heitbrock, Christopher E. Brightling, & David Parr. (2011). Assessing The Relationship Between Standardized CT Lung Densitometry And Airways Disease. A5222–A5222.
10.
Parr, David. (2011). Patient Phenotyping and Early Disease Detection in Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 8(4). 338–349. 17 indexed citations
11.
Stockley, Robert A., David Parr, Eeva Piitulainen, et al.. (2010). Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respiratory Research. 11(1). 136–136. 129 indexed citations
12.
Dirksen, Asger, Eeva Piitulainen, David Parr, et al.. (2009). Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency. European Respiratory Journal. 33(6). 1345–1353. 250 indexed citations
13.
Parr, David, Asger Dirksen, Eeva Piitulainen, et al.. (2009). Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respiratory Research. 10(1). 75–75. 67 indexed citations
14.
Parr, David & P Guest. (2008). Significance of Bronchiectasis in Patients with α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 178(2). 208–209. 1 indexed citations
15.
Parr, David, P Guest, John H. Reynolds, Lee Dowson, & Robert A. Stockley. (2007). Prevalence and Impact of Bronchiectasis in α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 176(12). 1215–1221. 150 indexed citations
16.
Parr, David, Andrew White, D Bayley, Peter Guest, & Robert A. Stockley. (2006). Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respiratory Research. 7(1). 136–136. 60 indexed citations
17.
Bakker, Margreet, Jan Stolk, Hein Putter, et al.. (2005). Variability in Densitometric Assessment of Pulmonary Emphysema With Computed Tomography. Investigative Radiology. 40(12). 777–783. 71 indexed citations
18.
Parr, David, Berend C. Stoel, Jan Stolk, & Robert A. Stockley. (2004). Pattern of Emphysema Distribution in α1-Antitrypsin Deficiency Influences Lung Function Impairment. American Journal of Respiratory and Critical Care Medicine. 170(11). 1172–1178. 154 indexed citations
19.
Parr, David, Berend C. Stoel, Jan Stolk, Peter Nightingale, & Robert A. Stockley. (2004). Influence of Calibration on Densitometric Studies of Emphysema Progression Using Computed Tomography. American Journal of Respiratory and Critical Care Medicine. 170(8). 883–890. 80 indexed citations
20.
Parr, David, et al.. (2003). Panniculitis secondary to extravasation of clarithromycin in a patient with alpha1-antitrypsin deficiency (phenotype PiZ). British Journal of Dermatology. 149(2). 410–413. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagi F. Khouri Breakdown of academic impact, for papers by Rocco Trisolini Breakdown of academic impact, for papers by Yoshiki Demura Breakdown of academic impact, for papers by Masako Chiyo Breakdown of academic impact, for papers by Hubert de Crémoux Breakdown of academic impact, for papers by Hirokazu Taniguchi Breakdown of academic impact, for papers by Jean M. Seely Breakdown of academic impact, for papers by J.-W.J. Lammers Breakdown of academic impact, for papers by Ian Woolhouse Breakdown of academic impact, for papers by Carlos A. Jiménez
Rankless by CCL
2026